Latkin Jed 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Latkin Jed
Interim COO
Transactions
- Award
Stock Option
2021-02-15$0.00/sh+100,000$100→ 100,000 totalExercise: $2.56Exp: 2031-02-15→ Common Stock (100,000 underlying)
Holdings
- 10,600(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.